Literature DB >> 4110088

Genetic history as a predictor of lithium response in manic-depressive illness.

J Mendlewicz, R R Fieve, F Stallone, J L Fleiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4110088     DOI： 10.1016/s0140-6736(72)90402-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Pharmacogenetics of bipolar disorder.

Authors:  Hader A Mansour; Martin Alda; Vishwajit L Nimgaonkar
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

2.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.

Authors:  Firoza Mamdani; Marcelo T Berlim; Marie-Martine Beaulieu; Gustavo Turecki
Journal:  World J Biol Psychiatry       Date:  2013-03-26       Impact factor: 4.132

3.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

Review 4.  Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.

Authors:  Firoza Mamdani; Iris Jaitovich Groisman; Martin Alda; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

5.  Lithium treatment in affective disorders.

Authors:  A K Tandon; R Asare; V C Saxena
Journal:  Indian J Psychiatry       Date:  1981-01       Impact factor: 1.759
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.